clover tirzepatide Eli Lilly's showed positive results in late-stage trial as treatment for heart failure regular virtual check New Trial Studying Tirzepatide for

Learn about TB-500 benefits and TB-500 alternatives

C3/C2 = propionyl-CoA carboxylase (elevated in propionic/methylmalonic acidemia)

Psychiatry 103, 109976

[7] Two trials in the phase 3 TRIUMPH program reached primary completion in April 2026: TRIUMPH-1, a master protocol in adults with obesity or overweight, and TRIUMPH-3, in participants with severe obesity and established cardiovascular disease

The ADA 2026 data on retatrutide and Foundayo, combined with Lilly's expanding partnerships, show how the company is trying to turn its obesity franchise into a broader cardiometabolic platform rather than a single-drug story

Do not microdose as a workaround for these contraindications